KBMED Cord Blood Collection Bag Enters Qatar Market
Updated: Oct 6
KBMED’s 250 mL CPD Cord Blood Collection Bag supports the collection stage of Qatar’s growing cord blood banking infrastructure
IRVINE, California — October 2026 — KB Medical Group Inc. (KBMED) has reached a new milestone in the Middle East with its 250 mL CPD Cord Blood Collection Bag entering the Qatar market.
Designed for the collection of umbilical cord blood, also known as placental blood, after childbirth, the specialized collection bag supports the critical first stage of the cord blood banking process. KBMED currently offers cord blood bags in 250 mL and 350 mL configurations, with CPD anticoagulant and 14G or 16G needle options.
The market development comes as Qatar continues to expand access to local cord blood banking services through a growing network of maternity hospitals.
Qatar Expands Access to Cord Blood Banking
Qatar is expanding access to local cord blood banking as Sidra Medicine, which operates the country’s only cord blood bank, extends its services across a growing network of maternity hospitals.
In 2026, Sidra Medicine announced agreements expanding access to cord blood banking for families delivering at The View Hospital and The Pearl International Hospital, while Aman Hospital became the first private hospital in Qatar to sign a separate cord blood banking agreement with Sidra Medicine.
This emerging model connects maternity hospitals with centralized cord blood processing, testing and long-term cryogenic storage at Sidra Medicine’s specialized GMP facility.
Maternity Hospitals → Cord Blood Collection → Transportation → Centralized Processing & Testing → Long-Term Storage
For medical device suppliers, the expansion of cord blood banking services also highlights the growing importance of reliable, standardized cord blood collection systems at the beginning of the banking workflow.
Supporting the Critical Collection Stage
Every cord blood banking journey begins with collection.
KBMED’s 250 mL CPD Cord Blood Collection Bag is designed specifically for collecting blood remaining in the umbilical cord and placenta after childbirth.
The current KBMED Cord Blood Collection Bag portfolio includes:
250 mL / 350 mL / customized bag configurations
CPD anticoagulant in the primary bag
14G and 16G needle options
Optional sampling device
Optional safety needle protector
Customized accessories
These configurations allow customers to select collection-system options according to their specific application and market requirements.
Why Qatar Is a Market to Watch
Qatar’s development is significant not simply because it has a domestic cord blood bank, but because access to cord blood banking is expanding through multiple maternity-care institutions while specialized downstream processing and storage remain centralized.
Sidra Medicine also states that it can transfer stored stem cells to authorized centers in other countries when required.
As hospital participation and access to cord blood banking continue to develop, KBMED sees Qatar as a market with potential for further development in standardized cord blood collection and banking services within the Gulf region.
This represents KBMED’s market perspective based on current developments and should not be interpreted as a prediction of Qatar’s future market size or regional position.
Expanding KBMED’s Transfusion Therapy Presence
The introduction of KBMED’s 250 mL Cord Blood Collection Bag in Qatar marks another step in the company’s expansion into specialized blood collection and transfusion therapy markets.
In addition to Cord Blood Collection Bags, KBMED’s broader Transfusion Therapy portfolio includes blood bags and related products for blood collection and administration. KB Med Group
For cord blood applications, KBMED remains focused on providing reliable collection solutions for cord blood banks, maternity healthcare programs, healthcare institutions and medical distributors.
Protecting a valuable biological resource begins with reliable collection.
From the First Drop, Quality Matters.
Market and healthcare information is provided for general informational purposes and reflects publicly available information as of October 2026. References to Qatar’s cord blood banking network do not imply a commercial relationship between KBMED and the healthcare institutions mentioned. Product availability and applicable regulatory requirements may vary by market and should be confirmed with the relevant local authorities and qualified regulatory professionals.
